Action Potential

Welcome back to Action Potential, join us this week as we welcome Dr. Paul Komenda, Chief Medical Officer, of Quanta Dialysis Technologies

What you'll get from this episode:
  • Dr. Paul Komenda's path from nephrologist to dialysis tech innovator.
  • Home hemodialysis program initiated by Dr. Komenda in Winnipeg.
  • Impact of remote physiological monitoring in home hemodialysis.
  • Technology's role in individualized education and support for CKD patients.
  • Need for policy frameworks and investments to drive CKD care innovations.
  • Envisioning nephrology's future with tech advancements and multidisciplinary collaboration.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Dr. Komenda: https://www.linkedin.com/in/paul-komenda-9536a924/?originalSubdomain=ca
And for more on Quanta Dialysis Technologies: https://www.quantadt.com/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

What is Action Potential?

Unveiling the Future of Potassium Monitoring. Dive into the nexus of medical innovation and clinical expertise, as we spotlight the game-changers in healthcare and explore the transformative power of continuous potassium data. Join us on a journey of discovery, from the intricacies of hyperkalemia to the voices that shape the future of patient-centric care. Powered by ProtonIntel’s groundbreaking technology, we’re setting new standards and redefining the pulse of modern medicine.